Picture of CellSource Co logo

4880 CellSource Co Cashflow Statement

0.000.00%
jp flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapFalling Star

Annual cashflow statement for CellSource Co, fiscal year end - October 31st, JPY millions except per share, conversion factor applied.

2021
October 31st
2022
October 31st
2023
October 31st
2024
October 31st
2025
October 31st
Period Length:12 M12 M12 M12 M12 M
Source:YuhoYuhoYuhoYuhoTanshin
Standards:
JAS
JAS
JAS
JAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line1,0061,5841,240295110
Depreciation
Non-Cash Items19.363.348.315992.4
Unusual Items
Other Non-Cash Items
Changes in Working Capital-158-845-505-4.54-67.4
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities898848847592333
Capital Expenditures-61.5-99.2-359-540-50.1
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-195-70.2-265-75.346.8
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-256-169-624-615-3.29
Financing Cash Flow Items0.8020.252-6-23.4-0.002
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities9.3514.41,449-43761.1
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash6527141,657-460391